PozNews - HIV News - STD News: Pfizer's Novel HIV/AIDS Treatment Selzentry™ (Maraviroc) Demonstrates Increased Efficacy Rate In Treatment-Naïve HIV Patients

Pfizer's Novel HIV/AIDS Treatment Selzentry™ (Maraviroc) Demonstrates
Increased Efficacy Rate In Treatment-Naïve HIV Patients
================================================================================
Medical News Today on 27 October, 2008 11:00:00
 
Patients taking Selzentry, in combination with Combivir®
(zidovudine/lamivudine) and selected by an enhanced sensitivity tropism test to
screen patients, experienced a 68 percent rate of virologic suppression to
undetectable levels, according to the MERIT ES (Reanalysis of the MERIT Study
wit